| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
14,972 |
12,168 |
$540K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,467 |
4,688 |
$275K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
2,700 |
2,480 |
$204K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
2,380 |
2,324 |
$194K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
10,724 |
5,238 |
$133K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
3,622 |
3,370 |
$132K |
| 99000 |
|
8,537 |
7,685 |
$89K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
946 |
925 |
$83K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,593 |
2,289 |
$56K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,760 |
3,479 |
$45K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
2,570 |
1,856 |
$20K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
152 |
148 |
$14K |
| 90461 |
|
2,892 |
2,055 |
$11K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
78 |
75 |
$10K |
| 99381 |
|
139 |
136 |
$10K |
| 87807 |
|
1,020 |
958 |
$9K |
| 99050 |
|
515 |
497 |
$8K |
| 90474 |
|
783 |
775 |
$7K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
265 |
262 |
$6K |
| 90670 |
|
1,433 |
1,410 |
$5K |
| 92551 |
|
1,025 |
975 |
$4K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
296 |
290 |
$4K |
| S8301 |
Infection control supplies, not otherwise specified |
363 |
319 |
$3K |
| 86328 |
|
61 |
50 |
$3K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
42 |
40 |
$2K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
30 |
29 |
$1K |
| 99383 |
|
13 |
13 |
$1K |
| 90680 |
|
1,268 |
1,236 |
$1K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
27 |
27 |
$1K |
| 90686 |
|
1,577 |
1,536 |
$1K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
111 |
85 |
$942.49 |
| 90677 |
|
423 |
402 |
$761.79 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
53 |
53 |
$730.19 |
| 96160 |
|
2,338 |
2,276 |
$545.09 |
| 0071A |
|
13 |
12 |
$480.00 |
| 81002 |
|
166 |
145 |
$418.33 |
| 98960 |
|
145 |
131 |
$253.81 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
14 |
12 |
$196.76 |
| 99051 |
|
27 |
27 |
$161.70 |
| 90633 |
|
743 |
720 |
$130.00 |
| 90648 |
|
1,299 |
1,271 |
$70.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
290 |
251 |
$68.59 |
| 84030 |
|
43 |
39 |
$50.82 |
| S8101 |
Holding chamber or spacer for use with an inhaler or nebulizer; with mask |
13 |
12 |
$27.00 |
| 90723 |
|
870 |
849 |
$20.00 |
| 92587 |
|
12 |
12 |
$18.24 |
| 90473 |
|
13 |
13 |
$15.68 |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
628 |
623 |
$15.00 |
| A7003 |
Administration set, with small volume nonfiltered pneumatic nebulizer, disposable |
14 |
12 |
$8.75 |
| 99172 |
|
178 |
177 |
$8.75 |
| 94760 |
|
18 |
15 |
$4.31 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
12 |
12 |
$2.04 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
21 |
15 |
$0.35 |
| G8482 |
Influenza immunization administered or previously received |
95 |
86 |
$0.00 |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
73 |
71 |
$0.00 |
| 99173 |
|
472 |
459 |
$0.00 |
| 1160F |
|
180 |
165 |
$0.00 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
92 |
79 |
$0.00 |
| 3078F |
|
44 |
40 |
$0.00 |
| 1033F |
|
195 |
180 |
$0.00 |
| 1159F |
|
218 |
200 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
59 |
45 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
17 |
13 |
$0.00 |
| 90707 |
|
83 |
83 |
$0.00 |
| 90734 |
|
24 |
24 |
$0.00 |
| 3725F |
|
30 |
29 |
$0.00 |
| 90715 |
|
12 |
12 |
$0.00 |
| G8483 |
Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) |
76 |
72 |
$0.00 |
| 94664 |
|
13 |
12 |
$0.00 |
| 90700 |
|
73 |
72 |
$0.00 |
| 90710 |
|
14 |
14 |
$0.00 |
| G8783 |
Normal blood pressure reading documented, follow-up not required |
15 |
13 |
$0.00 |
| 1126F |
|
339 |
312 |
$0.00 |
| 36416 |
|
715 |
691 |
$0.00 |
| 90656 |
|
339 |
339 |
$0.00 |
| H0033 |
Oral medication administration, direct observation |
233 |
221 |
$0.00 |
| 3008F |
|
375 |
358 |
$0.00 |
| 91307 |
|
19 |
14 |
$0.00 |
| 3074F |
|
97 |
90 |
$0.00 |
| 97802 |
|
90 |
88 |
$0.00 |
| 90744 |
|
41 |
38 |
$0.00 |
| 1036F |
|
14 |
13 |
$0.00 |
| S9451 |
Exercise classes, non-physician provider, per session |
58 |
56 |
$0.00 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
14 |
12 |
$0.00 |
| 96127 |
|
135 |
128 |
$0.00 |
| 90698 |
|
136 |
135 |
$0.00 |
| 90716 |
|
97 |
95 |
$0.00 |
| S3620 |
Newborn metabolic screening panel, includes test kit, postage and the laboratory tests specified by the state for inclusion in this panel (e.g., galactose; hemoglobin, electrophoresis; hydroxyprogesterone, 17-d; phenylalanine (pku); and thyroxine, total) |
13 |
12 |
$0.00 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
32 |
31 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
15 |
13 |
$0.00 |
| 90651 |
|
26 |
26 |
$0.00 |
| 4000F |
|
31 |
31 |
$0.00 |
| 90696 |
|
14 |
14 |
$0.00 |